BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35653914)

  • 21. Vascular cognitive impairment and vascular dementia.
    Rockwood K
    J Neurol Sci; 2002 Nov; 203-204():23-7. PubMed ID: 12417352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis.
    Custodero C; Ciavarella A; Panza F; Gnocchi D; Lenato GM; Lee J; Mazzocca A; Sabbà C; Solfrizzi V
    Geroscience; 2022 Jun; 44(3):1373-1392. PubMed ID: 35486344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment.
    Oveisgharan S; Dawe RJ; Yu L; Kapasi A; Arfanakis K; Hachinski V; Schneider JA; Bennett DA
    JAMA Neurol; 2022 Dec; 79(12):1277-1286. PubMed ID: 36279115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter-rater reliability of the diagnosis of vascular cognitive impairment at a memory clinic.
    Wentzel C; Darvesh S; MacKnight C; Shea C; Rockwood K
    Neuroepidemiology; 2000; 19(4):186-93. PubMed ID: 10859497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular aspects of cognitive impairment and dementia.
    Wiesmann M; Kiliaan AJ; Claassen JA
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1696-706. PubMed ID: 24022624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modern concept of vascular cognitive impairment.
    Bowler JV
    Br Med Bull; 2007; 83():291-305. PubMed ID: 17675645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional changes in brain oscillations in dementia: a review.
    Giustiniani A; Danesin L; Bozzetto B; Macina A; Benavides-Varela S; Burgio F
    Rev Neurosci; 2023 Jan; 34(1):25-47. PubMed ID: 35724724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing vascular cognitive impairment: Current challenges and future perspectives.
    Biesbroek JM; Biessels GJ
    Int J Stroke; 2023 Jan; 18(1):36-43. PubMed ID: 35098817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
    Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
    Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular cognitive impairment and dementia expenditures: 7-year inpatient cost description in community dwellers.
    Ramos-Estebanez C; Moral-Arce I; Rojo F; Gonzalez-Macias J; Hernandez JL
    Postgrad Med; 2012 Sep; 124(5):91-100. PubMed ID: 23095429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical activity in vascular cognitive impairment: Systematic review with meta-analysis.
    Vítor J; Melita C; Rodrigues M; de Sousa DA; Costa J; Ferro JM; Verdelho A
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107133. PubMed ID: 37156089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinico-radiological predictors of vascular cognitive impairment (VCI) in patients with stroke: a prospective observational study.
    Chaudhari TS; Verma R; Garg RK; Singh MK; Malhotra HS; Sharma PK
    J Neurol Sci; 2014 May; 340(1-2):150-8. PubMed ID: 24680559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia.
    Linh TTD; Hsieh YC; Huang LK; Hu CJ
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G
    BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?
    Andriuta D; Roussel M; Barbay M; Despretz-Wannepain S; Godefroy O;
    J Alzheimers Dis; 2018; 63(2):625-633. PubMed ID: 29689726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging therapies for vascular dementia and vascular cognitive impairment.
    Erkinjuntti T; Román G; Gauthier S; Feldman H; Rockwood K
    Stroke; 2004 Apr; 35(4):1010-7. PubMed ID: 15001795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.
    Moorhouse P; Song X; Rockwood K; Black S; Kertesz A; Gauthier S; Feldman H;
    J Neurol Sci; 2010 Jan; 288(1-2):142-6. PubMed ID: 19840883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia.
    Walker MP; Ayre GA; Cummings JL; Wesnes K; McKeith IG; O'Brien JT; Ballard CG
    Neurology; 2000 Apr; 54(8):1616-25. PubMed ID: 10762503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Brief Memory and Executive Test (BMET): A cognitive screening tool to detect and differentiate vascular cognitive impairment and Alzheimer's disease.
    Hollocks MJ; Brookes RL; Morris RG; Markus HS
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e273-e279. PubMed ID: 28881062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular cognitive impairment.
    O'Brien JT
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):724-33. PubMed ID: 16943169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.